dCROX and ROX Indices Predict Clinical Outcomes in Patients with COVID-19 Pneumonia Treated with High-Flow Nasal Cannula Oxygen Therapy.

Pitchayapa Ruchiwit Kanpisut Pongtongkam Narongkorn Saiphoklang

Published in: Critical care research and practice (2024)

ROX index has the highest accuracy for predicting successful weaning from HFNC in patients with COVID-19 pneumonia. dCROX index is the alternative tool for this setting. However, a larger prospective cohort study is needed to verify these indices for determining separation from HFNC therapy. This trial is registered with TCTR20221107004.

Keyphrases

respiratory failure
study protocol
mechanical ventilation
stem cells
extracorporeal membrane oxygenation
randomized controlled trial
phase iii
liquid chromatography
mass spectrometry
obstructive sleep apnea
phase ii
mesenchymal stem cells
acute respiratory distress syndrome
smoking cessation
sleep apnea